BREAKING: The FDA just made it official. Advisory committee meetings are now scheduled for July 23 24 to review reclassifying peptides back to legal compounding status. Here's what's happening: After the BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Is BPC157 Legal? WADA, FDA Status, and What You Need to Know Orthopedic Use of BPC 157 Sports Med Review BPC 157 Banned: Key Facts on the Latest FDA Decision BPC 157 500 mcg Oral Capsules